CY1118600T1 - Μεταλλικα νανοσωματιδια, παρασκευη και χρησεις αυτων - Google Patents
Μεταλλικα νανοσωματιδια, παρασκευη και χρησεις αυτωνInfo
- Publication number
- CY1118600T1 CY1118600T1 CY20171100166T CY171100166T CY1118600T1 CY 1118600 T1 CY1118600 T1 CY 1118600T1 CY 20171100166 T CY20171100166 T CY 20171100166T CY 171100166 T CY171100166 T CY 171100166T CY 1118600 T1 CY1118600 T1 CY 1118600T1
- Authority
- CY
- Cyprus
- Prior art keywords
- nanoparticles
- preparation
- concerns
- metallic nanoparticles
- size
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
- A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Η παρούσα δήλωση αφορά σε ενεργοποιήσιμα νανοσωματίδια τα οποία μπορεί να χρησιμοποιηθούν στον τομέα υγείας, ιδιαιτέρως στην ανθρώπινη υγεία, για να διαταράσσουν, μεταβάλλουν ή καταστρέφουν κύτταρα, ιστούς ή όργανα στόχους. Ειδικότερα αφορά σε νανοσωματίδια τα οποία μπορεί να δημιουργήσουν ένα σημαντικά ικανοποιητικό θεραπευτικό αποτέλεσμα, όταν εκτίθεται σε ιονίζουσες ακτινοβολίες. Το εφευρετικό νανοσωματίδιο είναι ένα μεταλλικό νανοσωματίδιο που έχει, ως το μεγαλύτερο μέγεθος, ένα μέγεθος περιλαμβανόμενο μεταξύ περίπου 80 και 105 nm, με το μέταλλο να έχει κατά προτίμηση ατομικό αριθμό (Ζ) τουλάχιστον 25. Η εφεύρεση επίσης αφορά σε φαρμακευτικές συνθέσεις που περιλαμβάνουν πληθυσμό νανοσωματιδίων όπως ορίζεται προηγουμένως, καθώς επίσης σε χρήσεις αυτών.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22457609P | 2009-07-10 | 2009-07-10 | |
| EP09165157A EP2275137A1 (en) | 2009-07-10 | 2009-07-10 | Metallic nanoparticles, preparation and uses thereof |
| EP10729917.4A EP2451481B1 (en) | 2009-07-10 | 2010-07-09 | Metallic nanoparticles, preparation and uses thereof |
| PCT/EP2010/059871 WO2011003999A1 (en) | 2009-07-10 | 2010-07-09 | Metallic nanoparticles, preparation and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1118600T1 true CY1118600T1 (el) | 2017-07-12 |
Family
ID=41110399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20171100166T CY1118600T1 (el) | 2009-07-10 | 2017-02-07 | Μεταλλικα νανοσωματιδια, παρασκευη και χρησεις αυτων |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US9700621B2 (el) |
| EP (3) | EP2275137A1 (el) |
| JP (1) | JP5739883B2 (el) |
| KR (1) | KR101670757B1 (el) |
| CN (1) | CN102470173B (el) |
| AU (1) | AU2010270225B2 (el) |
| BR (2) | BR112012000530B8 (el) |
| CA (1) | CA2765290C (el) |
| CY (1) | CY1118600T1 (el) |
| DK (2) | DK2451481T3 (el) |
| EA (1) | EA020942B1 (el) |
| ES (2) | ES2616628T3 (el) |
| HR (2) | HRP20170175T1 (el) |
| HU (2) | HUE052686T2 (el) |
| IL (1) | IL217287A (el) |
| LT (1) | LT2451481T (el) |
| MA (1) | MA33516B1 (el) |
| MX (2) | MX2012000285A (el) |
| NZ (1) | NZ597564A (el) |
| PL (2) | PL2451481T3 (el) |
| PT (2) | PT2451481T (el) |
| SG (2) | SG10201403832YA (el) |
| SI (1) | SI2451481T1 (el) |
| WO (1) | WO2011003999A1 (el) |
| ZA (1) | ZA201200902B (el) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102131575B1 (ko) | 2009-07-08 | 2020-07-08 | 클레네 나노메디슨, 인크. | 의학적 치료를 위한 신규한 금계 나노결정 및 이를 위한 전기화학 제조 방법 |
| EP2275137A1 (en) * | 2009-07-10 | 2011-01-19 | Nanobiotix | Metallic nanoparticles, preparation and uses thereof |
| US20120190979A1 (en) | 2011-01-24 | 2012-07-26 | Actium BioSystems, LLC | System for automatically amending energy field characteristics in the application of an energy field to a living organism for treatment of invasive agents |
| CA2846094C (en) * | 2011-08-26 | 2017-06-20 | Actium BioSystems, LLC | Apparatus for the generation of an energy field for the treatment of cancer in body cavities and parts that are cavity-like |
| PL2790682T3 (pl) | 2011-12-16 | 2019-08-30 | Nanobiotix | Nanocząstki zawierające materiał metaliczny i materiał tlenku hafnu, ich wytwarzanie i zastosowanie |
| EA034242B1 (ru) * | 2013-01-25 | 2020-01-21 | Нанобиотикс | Способ индуцирования снижения размера опухоли у субъекта-человека, имеющего рак |
| US10413509B2 (en) * | 2013-05-30 | 2019-09-17 | Nanobiotix | Pharmaceutical composition, preparation and uses thereof |
| CA2915430A1 (en) * | 2013-06-20 | 2014-12-24 | Nanobiotix | Compositions and methods for use in medical diagnosis |
| TWI689310B (zh) | 2014-07-11 | 2020-04-01 | 巨生生醫股份有限公司 | 治療鐵缺乏症之方法 |
| JP6778371B2 (ja) * | 2015-01-23 | 2020-11-04 | ミヨシ油脂株式会社 | 金微粒子マトリックスメタロプロテアーゼ阻害剤 |
| BR112017025553A2 (pt) | 2015-05-28 | 2018-08-07 | Nanobiotix | composição de vacina, e kit |
| DE102017101057A1 (de) * | 2017-01-20 | 2018-07-26 | Fraunhofer-Institut für Angewandte Polymerforschung IAP | Zwitterionische Nanopartikel |
| JP7376901B2 (ja) * | 2017-11-13 | 2023-11-09 | 国立大学法人北海道大学 | 修飾金属ナノ粒子及び医薬組成物 |
| CN110883341B (zh) * | 2018-09-11 | 2021-03-30 | 清华大学 | 金纳米团簇制备方法 |
| US20220348737A1 (en) * | 2019-09-27 | 2022-11-03 | Kyoto University | Porus silica-containing nanoparticles, production method therefor, and pharmaceutical compostion for radiation treatment |
| KR20230038659A (ko) * | 2020-05-26 | 2023-03-21 | 나노비오띡스 | 나노 입자, 전리 방사선 및 그의 혁신적인 치료용 조합 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000006244A2 (en) * | 1998-07-30 | 2000-02-10 | Hainfeld James F | Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy |
| US20070031337A1 (en) * | 2004-06-22 | 2007-02-08 | Reinhard Schulte | Nanoparticle enhanced proton computed tomography and proton therapy |
| DE102007040934A1 (de) | 2007-08-30 | 2009-03-05 | Man Diesel A/S | Verfahren und Vorrichtung zur Reinigung von Abgas |
| EP2130553A1 (en) * | 2008-06-05 | 2009-12-09 | Nanobiotix | Inorganic nanoparticles of high density to destroy cells in-vivo |
| EP2275137A1 (en) * | 2009-07-10 | 2011-01-19 | Nanobiotix | Metallic nanoparticles, preparation and uses thereof |
-
2009
- 2009-07-10 EP EP09165157A patent/EP2275137A1/en not_active Withdrawn
-
2010
- 2010-07-09 PT PT107299174T patent/PT2451481T/pt unknown
- 2010-07-09 MX MX2012000285A patent/MX2012000285A/es active IP Right Grant
- 2010-07-09 EP EP17152585.0A patent/EP3178494B1/en active Active
- 2010-07-09 HU HUE17152585A patent/HUE052686T2/hu unknown
- 2010-07-09 BR BR112012000530A patent/BR112012000530B8/pt not_active IP Right Cessation
- 2010-07-09 LT LTEP10729917.4T patent/LT2451481T/lt unknown
- 2010-07-09 MX MX2015010613A patent/MX347606B/es unknown
- 2010-07-09 PL PL10729917T patent/PL2451481T3/pl unknown
- 2010-07-09 SI SI201031410A patent/SI2451481T1/sl unknown
- 2010-07-09 DK DK10729917.4T patent/DK2451481T3/en active
- 2010-07-09 AU AU2010270225A patent/AU2010270225B2/en not_active Ceased
- 2010-07-09 ES ES10729917.4T patent/ES2616628T3/es active Active
- 2010-07-09 US US13/383,049 patent/US9700621B2/en active Active
- 2010-07-09 EA EA201270154A patent/EA020942B1/ru not_active IP Right Cessation
- 2010-07-09 CA CA2765290A patent/CA2765290C/en active Active
- 2010-07-09 BR BR122019025997A patent/BR122019025997B8/pt not_active IP Right Cessation
- 2010-07-09 PT PT171525850T patent/PT3178494T/pt unknown
- 2010-07-09 CN CN201080031148.1A patent/CN102470173B/zh active Active
- 2010-07-09 ES ES17152585T patent/ES2837412T3/es active Active
- 2010-07-09 SG SG10201403832YA patent/SG10201403832YA/en unknown
- 2010-07-09 PL PL17152585T patent/PL3178494T3/pl unknown
- 2010-07-09 SG SG2012002044A patent/SG177611A1/en unknown
- 2010-07-09 WO PCT/EP2010/059871 patent/WO2011003999A1/en active Application Filing
- 2010-07-09 EP EP10729917.4A patent/EP2451481B1/en active Active
- 2010-07-09 KR KR1020127003701A patent/KR101670757B1/ko active IP Right Grant
- 2010-07-09 NZ NZ597564A patent/NZ597564A/xx not_active IP Right Cessation
- 2010-07-09 JP JP2012519006A patent/JP5739883B2/ja active Active
- 2010-07-09 DK DK17152585.0T patent/DK3178494T3/da active
- 2010-07-09 HU HUE10729917A patent/HUE031796T2/en unknown
-
2011
- 2011-12-29 IL IL217287A patent/IL217287A/en active IP Right Grant
-
2012
- 2012-02-07 ZA ZA2012/00902A patent/ZA201200902B/en unknown
- 2012-02-08 MA MA34614A patent/MA33516B1/fr unknown
-
2017
- 2017-02-02 HR HRP20170175TT patent/HRP20170175T1/hr unknown
- 2017-02-07 CY CY20171100166T patent/CY1118600T1/el unknown
- 2017-06-28 US US15/635,252 patent/US10391174B2/en active Active
-
2020
- 2020-12-15 HR HRP20202005TT patent/HRP20202005T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118600T1 (el) | Μεταλλικα νανοσωματιδια, παρασκευη και χρησεις αυτων | |
| MX369664B (es) | Composiciones de nanoparticulas inorganicas en combinacion con radiaciones ionizantes para tratar el cancer. | |
| CY1119123T1 (el) | Δις-αρυλοσυζευγμενες αρυλοτριαζολονες και η χρηση τους | |
| MX2019001920A (es) | Arn la terapia contra el cancer. | |
| CY1108369T1 (el) | Σωματιδια ενεργοποιησιμα με ακτινες χ και/ή uv, παρασκευη και θεραπευτικες ή διαγνωστικες χρησεις αυτων | |
| CY1123983T1 (el) | Ειδικα σε axl συζευγματα αντισωματος-φαρμακου για τη θεραπεια καρκινου | |
| MX2015000821A (es) | Compuestos para inmunoterapia dirigida. | |
| CY1116590T1 (el) | Υλικα πολυ οξο-υδροξυ μεταλλικου ιοντος τροποποιημενα με εκλεκτικο συνδετη, χρησεις αυτων και μεθοδοι παρασκευης αυτων | |
| BR112015016466A2 (pt) | método para o tratamento de câncer baseado no estado de mutação de k-ras | |
| CY1120736T1 (el) | Συνθεσεις και μεθοδοι αναστολης masp-1, masp-2 ή/και masp-3 για θεραπεια παροξυσμικης νυχτερινης αιμοσφαιρινουριας | |
| MX2015011583A (es) | Derivados de amatoxina. | |
| CR10975A (es) | Formulaciones para el tratamiento del cancer | |
| CY1116781T1 (el) | Σιλυλ πολυμερεις βενζοϊκου οξεος εστερα ενωσεις, χρησεις και συνδεσεις αυτων | |
| BR112014026801A2 (pt) | 5-[[4-[[morfolin-2-il]metilamino]-5-(trifluorometil)-2-piridil]amino]pirazina-2-carbonitrila e usos terapêuticos do mesmo | |
| EP3566750A3 (en) | Conjugates comprising cell-binding agents and cytotoxic agents | |
| CY1122892T1 (el) | Παραγωγα 3-(καρβοξυμεθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου | |
| CY1123216T1 (el) | Αναστολεις της gls1 για την αντιμετωπιση νοσων | |
| CY1123366T1 (el) | Παραγωγα 8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δeκανιου | |
| CY1122818T1 (el) | Παραγωγα 3-((ετερο-)αρυλ)-αλκυλ-8-αμινο-2-οξο-1,3-διαζα- σπε1ρο-[4.5]-δεκανιου | |
| CY1122923T1 (el) | Παραγωγα 3-((ετερο-)αρυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου | |
| NZ745187A (en) | 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives | |
| MX2017015293A (es) | Composicion para tratar lesiones tisulares. | |
| CY1121611T1 (el) | Νανοσωματιδιακο παρασκευασμα που περιλαμβανει εναν αναστολεα της mpges-1 | |
| NZ750194A (en) | Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer | |
| TH158872A (th) | องค์ประกอบอนุภาคนาโนอนินทรีย์ร่วมกับรังสีไอออไนซ์สำหรับการรักษามะเร็ง |